Vaporized Nicotine (E-Cigarette) and Tobacco Smoking Among People With HIV: Use Patterns and Associations With Depression and Panic Symptoms

aDepartment of Medicine, University of Washington, Seattle, WA;

bCollege of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada;

cDepartment of Medicine, Harvard Medical School, Fenway Institute, Boston, MA;

dDepartment of Psychiatry, Harvard Medical School, Fenway Institute, Boston, MA;

eDepartment of Medicine, University of North Carolina, Chapel Hill, NC;

fDepartment of Medicine, University of California San Francisco, San Francisco, CA;

gDepartment of Medicine, University of California San Diego, San Diego, CA;

hDepartment of Medicine, Case Western University, Cleveland, OH;

iDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL; and

jDepartment of Psychiatry, University of Alabama at Birmingham, Birmingham, AL

Correspondence to: Andrew W. Hahn MD, Department of Medicine, University of Washington, 325 9th Ave, Seattle, WA 98104 (e-mail: [email protected]).

Supported in part by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health (P01 AA029544, U24AA020801, U01AA020793, and U01AA020802) and the National Institute on Drug Abuse (NIDA) (R01DA047045 and R21DA047891). Additional support came from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (CNICS R24 AI067039, UW CFAR NIAID Grant P30 AI027757, UNC CFAR Grant P30 AI50410, and UAB CFAR Grant P30 AI027767).

The authors have no conflicts of interest to disclose.

Presented at the 37th International Society for Pharmacoepidemiology Conference; August 24 2021; Virtual.

留言 (0)

沒有登入
gif